CompletedNCT02782104
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression
This study evaluated the safety of Esketamine Nasal Spray for people with depression.
Medication studyAges 18+Multiple countries
Understand this study
What did researchers investigate?
This study evaluated the safety of Esketamine Nasal Spray for people with depression.
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Birmingham and 172 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: June 9, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 1,148
- Sponsor
- Janssen Research & Development, LLC
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Australia, France, ...
- Age range
- Over 18 Years
- Official registry ID
- NCT02782104
- Official title
Show the full official title
An Open-label Long-term Extension Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression
Recruitment & locations
CompletedBirmingham, United States · Little Rock, United States · Garden Grove, United States
172 more locations
- Glendale, United States
- Oakland, United States
- Orange, United States
- San Diego, United States
- San Rafael, United States
- Hartford, United States
- New Haven, United States
- Gainesville, United States
- Miami, United States
- Orlando, United States
- Atlanta, United States
- Chicago, United States
- Hoffman Estates, United States
- Joliet, United States
- Maywood, United States
- Skokie, United States
- Iowa City, United States
- Wichita, United States
- Lake Charles, United States
- Shreveport, United States
- Baltimore, United States
- Gaithersburg, United States
- Boston, United States
- New Bedford, United States
- Watertown, United States
- Worcester, United States
- Rochester Hills, United States
- O'Fallon, United States
- Saint Charles, United States
- Omaha, United States
- Cedarhurst, United States
- New York, United States
- Staten Island, United States
- Hickory, United States
- Cincinnati, United States
- Oklahoma City, United States
- Allentown, United States
- Media, United States
- Philadelphia, United States
- Lincoln, United States
- Providence, United States
- Charleston, United States
- Austin, United States
- Dallas, United States
- Houston, United States
- Wichita Falls, United States
- Charlottesville, United States
- Waukesha, United States
- Banfield, Argentina
- Buenos Aires, Argentina
- Córdoba, Argentina
- La Plata, Argentina
- Mendoza, Argentina
- Rosario, Argentina
- Caulfield, Australia
- Elizabeth Vale, Australia
- Frankston, Australia
- Vienna, Austria
- Aalst, Belgium
- Bruges, Belgium
- Brussels, Belgium
- Heusden-Zolder, Belgium
- Liège, Belgium
- Yvoir, Belgium
- Belo Horizonte, Brazil
- Curitiba, Brazil
- Fortaleza, Brazil
- Passo Fundo, Brazil
- Porto Alegre, Brazil
- Recife, Brazil
- Rio de Janeiro, Brazil
- São Bernardo do Campo, Brazil
- São Paulo, Brazil
- Burgas, Bulgaria
- Kardzhali, Bulgaria
- Pazardzhik, Bulgaria
- Pleven, Bulgaria
- Plovdiv, Bulgaria
- Rousse, Bulgaria
- Sofia, Bulgaria
- Varna, Bulgaria
- Vancouver, Canada
- Kingston, Canada
- Ottawa, Canada
- Toronto, Canada
- Brno, Czechia
- Pilsen, Czechia
- Prague, Czechia
- Tallinn, Estonia
- Tartu, Estonia
- Kuopio, Finland
- Clermont-Ferrand, France
- Douai, France
- Nantes, France
- Nîmes, France
- Paris, France
- Poitiers, France
- Toulon, France
- Berlin, Germany
- Bochum, Germany
- Mainz, Germany
- Mittweida, Germany
- Oranienburg, Germany
- Pfaffenhofen, Germany
- Budapest, Hungary
- Debrecen, Hungary
- Győr, Hungary
- Pécs, Hungary
- Sopron, Hungary
- Szekszárd, Hungary
- Vác, Hungary
- Kaunas, Lithuania
- Kuala Lumpur, Malaysia
- Guadalajara, Mexico
- León, Mexico
- Mexico City, Mexico
- México, Mexico
- Monterrey, Mexico
- San Luis Potosí City, Mexico
- Bełchatów, Poland
- Bialystok, Poland
- Bydgoszcz, Poland
- Gdansk, Poland
- Leszno, Poland
- Lublin, Poland
- Warsaw, Poland
- Bratislava, Slovakia
- Liptovský Mikuláš, Slovakia
- Rimavská Sobota, Slovakia
- Rožňava, Slovakia
- Svidník, Slovakia
- Cape Town, South Africa
- Pretoria, South Africa
- Welgemoed, South Africa
- Gwangju, South Korea
- Seoul, South Korea
- Alcorcón, Spain
- Barcelona, Spain
- Bilbao, Spain
- Madrid, Spain
- Oviedo, Spain
- Palma, Spain
- Pamplona, Spain
- Sabadell, Spain
- Salamanca, Spain
- Sant Boi de Llobregat, Spain
- Torrevieja, Spain
- Vitoria-Gasteiz, Spain
- Zamora, Spain
- Halmstad, Sweden
- Lund, Sweden
- Skövde, Sweden
- Stockholm, Sweden
- Kaohsiung City, Taiwan
- New Taipei City, Taiwan
- Taichung, Taiwan
- Taipei, Taiwan
- Taoyuan, Taiwan
- Adana, Türkiye
- Ankara, Türkiye
- Bursa, Türkiye
- Istanbul, Türkiye
- Kucukcekmece/Istanbul, Türkiye
- Oanakkale, Türkiye
- Samsun, Türkiye
- Chesterfield, United Kingdom
- Derby, United Kingdom
- London, United Kingdom
- Northampton, United Kingdom
- Oxford, United Kingdom
- Czechia
- Türkiye
Questions about this study
What did researchers investigate?
This study evaluated the safety of Esketamine Nasal Spray for people with depression.
Who is behind this study?
The study sponsor is Janssen Research & Development, LLC.
Did this study involve medication?
Yes. The study involved medication, including Esketamine Nasal Spray.
Who was this study for?
Listed age limits: from 18 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me